Document Format Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
1 | ANNUAL REPORT | f20f2021_biondvax.htm iXBRL | 20-F | 2439257 |
2 | EMPLOYMENT AGREEMENT DATED JANUARY 20, 2021, BETWEEN BIONDVAX PHARMACEUTICALS LT | f20f2021ex4-4_biondvax.htm | EX-4.4 | 84052 |
3 | LICENSE AGREEMENT, DATED DECEMBER 11, 2021, BETWEEN BIONDVAX PHARMACEUTICALS LTD | f20f2021ex4-16_biondvax.htm | EX-4.16 | 45697 |
4 | ACCOMPANYING RESEARCH COLLABORATION AGREEMENT, DATED DECEMBER 11, 2021 | f20f2021ex4-17_biondvax.htm | EX-4.17 | 35020 |
5 | RESEARCH COLLABORATION AGREEMENT, DATED MARCH 23, 2022, BETWEEN BIONDVAX PHARMAC | f20f2021ex4-18_biondvax.htm | EX-4.18 | 329555 |
6 | FORM OF LICENSE AGREEMENT BETWEEN BIONDVAX PHARMACEUTICALS LTD., MAX-PLANCK-GESE | f20f2021ex4-19_biondvax.htm | EX-4.19 | 483781 |
7 | CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A M | f20f2021ex10_biondvax.htm | EX-10 | 1838 |
8 | CERTIFICATION | f20f2021ex12-1_biondvax.htm | EX-12.1 | 10161 |
9 | CERTIFICATION | f20f2021ex12-2_biondvax.htm | EX-12.2 | 10270 |
10 | CERTIFICATION | f20f2021ex13-1_biondvax.htm | EX-13.1 | 3684 |
11 | CERTIFICATION | f20f2021ex13-2_biondvax.htm | EX-13.2 | 3541 |
17 | GRAPHIC | ex10-16_001.jpg | GRAPHIC | 65650 |
18 | GRAPHIC | ex10-16_002.jpg | GRAPHIC | 358133 |
19 | GRAPHIC | ex10-16_003.jpg | GRAPHIC | 297199 |
20 | GRAPHIC | ex10-16_004.jpg | GRAPHIC | 304720 |
21 | GRAPHIC | ex10-16_005.jpg | GRAPHIC | 352470 |
22 | GRAPHIC | ex10-16_006.jpg | GRAPHIC | 274921 |
23 | GRAPHIC | ex10-16_007.jpg | GRAPHIC | 344527 |
24 | GRAPHIC | ex10-16_008.jpg | GRAPHIC | 273359 |
25 | GRAPHIC | ex10-16_009.jpg | GRAPHIC | 327862 |
26 | GRAPHIC | ex10-16_010.jpg | GRAPHIC | 372918 |
27 | GRAPHIC | ex10-16_011.jpg | GRAPHIC | 356238 |
28 | GRAPHIC | ex10-16_012.jpg | GRAPHIC | 301319 |
29 | GRAPHIC | ex10-16_013.jpg | GRAPHIC | 342982 |
30 | GRAPHIC | ex10-16_014.jpg | GRAPHIC | 271628 |
31 | GRAPHIC | ex10-16_015.jpg | GRAPHIC | 356283 |
32 | GRAPHIC | ex10-16_016.jpg | GRAPHIC | 334967 |
33 | GRAPHIC | ex10-16_017.jpg | GRAPHIC | 330849 |
34 | GRAPHIC | ex10-16_018.jpg | GRAPHIC | 363334 |
35 | GRAPHIC | ex10-16_019.jpg | GRAPHIC | 343836 |
36 | GRAPHIC | ex10-16_020.jpg | GRAPHIC | 327535 |
37 | GRAPHIC | ex10-16_021.jpg | GRAPHIC | 308054 |
38 | GRAPHIC | ex10-16_022.jpg | GRAPHIC | 302160 |
39 | GRAPHIC | ex10-16_023.jpg | GRAPHIC | 363464 |
40 | GRAPHIC | ex10-16_024.jpg | GRAPHIC | 310164 |
41 | GRAPHIC | ex10-16_025.jpg | GRAPHIC | 171416 |
42 | GRAPHIC | ex10-16_026.jpg | GRAPHIC | 237254 |
43 | GRAPHIC | ex10-16_027.jpg | GRAPHIC | 185317 |
44 | GRAPHIC | ex10-16_028.jpg | GRAPHIC | 119017 |
45 | GRAPHIC | ex10-16_029.jpg | GRAPHIC | 288244 |
46 | GRAPHIC | ex10-16_030.jpg | GRAPHIC | 207522 |
47 | GRAPHIC | ex10-16_031.jpg | GRAPHIC | 277913 |
48 | GRAPHIC | ex10-16_032.jpg | GRAPHIC | 295751 |
49 | GRAPHIC | ex10-16_033.jpg | GRAPHIC | 310982 |
50 | GRAPHIC | ex10-16_034.jpg | GRAPHIC | 334972 |
51 | GRAPHIC | ex10-16_035.jpg | GRAPHIC | 374541 |
52 | GRAPHIC | ex10-16_036.jpg | GRAPHIC | 310910 |
53 | GRAPHIC | ex10-16_037.jpg | GRAPHIC | 337707 |
54 | GRAPHIC | ex10-16_038.jpg | GRAPHIC | 344264 |
55 | GRAPHIC | ex10-16_039.jpg | GRAPHIC | 324064 |
56 | GRAPHIC | ex10-16_040.jpg | GRAPHIC | 281633 |
57 | GRAPHIC | ex10-16_041.jpg | GRAPHIC | 216305 |
58 | GRAPHIC | ex10-16_042.jpg | GRAPHIC | 340897 |
59 | GRAPHIC | ex10-16_043.jpg | GRAPHIC | 341206 |
60 | GRAPHIC | ex10-16_044.jpg | GRAPHIC | 297913 |
61 | GRAPHIC | ex10-16_045.jpg | GRAPHIC | 182925 |
62 | GRAPHIC | ex10-16_046.jpg | GRAPHIC | 353455 |
63 | GRAPHIC | ex10-16_047.jpg | GRAPHIC | 307805 |
64 | GRAPHIC | ex10-16_048.jpg | GRAPHIC | 260184 |
65 | GRAPHIC | ex10-16_049.jpg | GRAPHIC | 80959 |
66 | GRAPHIC | ex10-16_050.jpg | GRAPHIC | 24312 |
67 | GRAPHIC | ex10-16_051.jpg | GRAPHIC | 23056 |
68 | GRAPHIC | ex10-16_052.jpg | GRAPHIC | 44300 |
69 | GRAPHIC | ex10-16_053.jpg | GRAPHIC | 43817 |
70 | GRAPHIC | ex10-16_054.jpg | GRAPHIC | 26968 |
71 | GRAPHIC | ex10-16_055.jpg | GRAPHIC | 25669 |
72 | GRAPHIC | ex10-16_056.jpg | GRAPHIC | 28530 |
73 | GRAPHIC | ex10-16_057.jpg | GRAPHIC | 27393 |
74 | GRAPHIC | ex10-16_058.jpg | GRAPHIC | 26629 |
75 | GRAPHIC | ex10-16_059.jpg | GRAPHIC | 24741 |
76 | GRAPHIC | ex10-16_060.jpg | GRAPHIC | 52663 |
77 | GRAPHIC | ex10-16_061.jpg | GRAPHIC | 47500 |
78 | GRAPHIC | ex10-16_062.jpg | GRAPHIC | 67244 |
79 | GRAPHIC | ex10-16_063.jpg | GRAPHIC | 65202 |
80 | GRAPHIC | ex10-17_001.jpg | GRAPHIC | 113442 |
81 | GRAPHIC | ex10-17_002.jpg | GRAPHIC | 337629 |
82 | GRAPHIC | ex10-17_003.jpg | GRAPHIC | 278213 |
83 | GRAPHIC | ex10-17_004.jpg | GRAPHIC | 311700 |
84 | GRAPHIC | ex10-17_005.jpg | GRAPHIC | 270858 |
85 | GRAPHIC | ex10-17_006.jpg | GRAPHIC | 298870 |
86 | GRAPHIC | ex10-17_007.jpg | GRAPHIC | 297475 |
87 | GRAPHIC | ex10-17_008.jpg | GRAPHIC | 272859 |
88 | GRAPHIC | ex10-17_009.jpg | GRAPHIC | 342199 |
89 | GRAPHIC | ex10-17_010.jpg | GRAPHIC | 307071 |
90 | GRAPHIC | ex10-17_011.jpg | GRAPHIC | 371816 |
91 | GRAPHIC | ex10-17_012.jpg | GRAPHIC | 341169 |
92 | GRAPHIC | ex10-17_013.jpg | GRAPHIC | 222691 |
93 | GRAPHIC | ex10-17_014.jpg | GRAPHIC | 316732 |
94 | GRAPHIC | ex10-17_015.jpg | GRAPHIC | 382700 |
95 | GRAPHIC | ex10-17_016.jpg | GRAPHIC | 392808 |
96 | GRAPHIC | ex10-17_017.jpg | GRAPHIC | 409129 |
97 | GRAPHIC | ex10-17_018.jpg | GRAPHIC | 144378 |
98 | GRAPHIC | ex10-17_019.jpg | GRAPHIC | 215643 |
99 | GRAPHIC | ex10-17_020.jpg | GRAPHIC | 404794 |
100 | GRAPHIC | ex10-17_021.jpg | GRAPHIC | 296860 |
101 | GRAPHIC | ex10-17_022.jpg | GRAPHIC | 315326 |
102 | GRAPHIC | ex10-17_023.jpg | GRAPHIC | 284078 |
103 | GRAPHIC | ex10-17_024.jpg | GRAPHIC | 243153 |
104 | GRAPHIC | ex10-17_025.jpg | GRAPHIC | 56781 |
105 | GRAPHIC | ex10-17_026.jpg | GRAPHIC | 115955 |
106 | GRAPHIC | ex10-17_027.jpg | GRAPHIC | 31290 |
107 | GRAPHIC | ex10-17_028.jpg | GRAPHIC | 54310 |
108 | GRAPHIC | ex10-17_029.jpg | GRAPHIC | 250293 |
109 | GRAPHIC | ex10-17_030.jpg | GRAPHIC | 44833 |
110 | GRAPHIC | ex10-17_031.jpg | GRAPHIC | 38770 |
111 | GRAPHIC | ex10-17_032.jpg | GRAPHIC | 39180 |
112 | GRAPHIC | ex10-17_033.jpg | GRAPHIC | 26944 |
113 | GRAPHIC | ex10-17_034.jpg | GRAPHIC | 198614 |
114 | GRAPHIC | ex10-17_035.jpg | GRAPHIC | 39735 |
115 | GRAPHIC | ex10-17_036.jpg | GRAPHIC | 40108 |
116 | GRAPHIC | ex10-17_037.jpg | GRAPHIC | 39778 |
117 | GRAPHIC | ex10-17_038.jpg | GRAPHIC | 40112 |
118 | GRAPHIC | fin_001.jpg | GRAPHIC | 25395 |
Complete submission text file | 0001213900-22-015270.txt | 42482853 |
Data Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
12 | XBRL SCHEMA FILE | bvxv-20211231.xsd | EX-101.SCH | 118565 |
13 | XBRL CALCULATION FILE | bvxv-20211231_cal.xml | EX-101.CAL | 30113 |
14 | XBRL DEFINITION FILE | bvxv-20211231_def.xml | EX-101.DEF | 302449 |
15 | XBRL LABEL FILE | bvxv-20211231_lab.xml | EX-101.LAB | 644363 |
16 | XBRL PRESENTATION FILE | bvxv-20211231_pre.xml | EX-101.PRE | 314962 |
189 | EXTRACTED XBRL INSTANCE DOCUMENT | f20f2021_biondvax_htm.xml | XML | 1746726 |
IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-37353 | Film No.: 22773136
SIC: 2836 Biological Products, (No Diagnostic Substances)